Reveal HealthTech secures $7.2M Series A to accelerate AI adoption in healthcare with Leo Capital leading investment

Reveal HealthTech Secures $7.2M Series A to Advance AI in Healthcare

NEW YORK and BANGALORE, India, Sept. 3, 2025 – Reveal HealthTech, a focused AI transformation partner for U.S. healthcare and life sciences companies, announced closing a $7.2 million Series A funding round. The round was led by Leo Capital with participation from Sanos Capital.

Founded in 2023 and incubated by W Health Ventures and 2070 Health, Reveal has quickly established itself as an AI specialist blending advanced artificial intelligence with deep healthcare knowledge. The company helps healthcare organizations pinpoint critical challenges and develop clinically sound AI systems that address them safely.

Driving Practical AI Solutions in Healthcare

Dr. Sumir Sahgal, founder and Chief Medical Officer at Essen Health Care, a New York-based integrated healthcare delivery network, explained how AI transforms patient care: "Each year, across hundreds of thousands of patient interactions, we've seen how compassion combined with intelligence enhances care. With Reveal, our vision of empathetic, personalized care is becoming a reality. Acting on real-time data improves patient experience and reduces clinician workload."

AI applications in healthcare are now mainstream, reshaping diagnosis, treatment, and operational workflows. Reveal HealthTech stands out by combining academic excellence from institutions like MIT, Harvard Medical, and UC Berkeley with deep technology experience from organizations such as Boston Children's Hospital, SpaceX, NASA, and Athena Health.

A Clear Mission Backed by Industry Leaders

Sanchit Mullick, Founder of Reveal HealthTech, emphasized the company’s straightforward goal: "We want AI to be the most trusted and accountable partner in healthcare. Our solutions support everyone from Fortune 100 pharma companies and large healthcare systems to emerging digital health innovators."

Reveal’s flagship products include:

• BioCanvas®: Enables multimodal AI applications like accelerating clinical trial recruitment through AI-driven insights.
• Prism AI®: Facilitates fast development of intelligent agents to automate healthcare workflows.

In a recent project with a $40 billion US medical device company, Reveal improved patient adherence by integrating AI insights and creating reusable frameworks for other clients.

Investor Perspectives

Rajul Garg, Partner at Leo Capital, shared, "Meeting the Reveal team showed us their strength lies in creating practical AI solutions that deliver measurable business value quickly. We're excited to support their next phase of growth." Rajul brings experience from co-founding Pine Labs and GlobalLogic, a leading digital engineering firm.

Dr. Pankaj Jethwani, Managing Partner at W Health Ventures, added, "Healthcare requires solutions that fit unique challenges. Reveal understands this well. Supporting their growth aligns with the accelerating adoption of AI in US healthcare."

Next Steps for Reveal HealthTech

The Series A funds will help Reveal enhance its technology offerings, expand its sales reach, and engage more leaders in healthcare and life sciences globally. Reveal also recently joined the Cipher Collective, an ECG-powered AI partner network uniting top health technology solutions to improve care delivery.

About Reveal HealthTech

Reveal HealthTech specializes in AI transformation for healthcare and life sciences organizations in the US. It delivers custom AI solutions that combine clinical expertise and engineering skill to solve pressing business and clinical challenges.

About Leo Capital

Leo Capital is a venture capital fund investing in early-stage technology startups across the US, India, and Europe. They focus on cross-border opportunities and maintain a diverse portfolio of over 50 companies.

About Sanos Capital

Sanos Capital is a New York-based venture capital fund dedicated to digital health. Led by experienced operators, Sanos partners with visionary founders to scale technologies that transform care delivery and enhance patient experience.

About W Health Ventures

W Health Ventures is an early-stage venture capital firm focused on building healthcare companies that leverage AI-enabled solutions and innovative care delivery models primarily in the US-India corridor.

For healthcare professionals interested in how AI is reshaping the industry, exploring practical AI training and courses can provide valuable insights. Resources like Complete AI Training's latest AI courses offer relevant learning paths tailored for healthcare roles.